Immunovia AB ( IMMVF) - Key Metrics
IMMVF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.03 | -$0.03 | -$0.03 |
| 2026Q1 | $0 | -$0.03 | -$0.03 | -$0.03 |
| 2025Q4 | $0 | -$0.03 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.08 | -$0.04 | -$0.06 |
| 2025Q2 | $0 | -$0.14 | -$0.06 | -$0.06 |
IMMVF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.62 |
| 2026Q1 | 0% | -1.72 |
| 2025Q4 | 0% | -1.43 |
| 2025Q3 | 0% | -1.59 |
| 2025Q2 | 0% | -0.88 |
IMMVF
Price: $0.01
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 3.1 million